nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—Epirubicin—ovarian cancer	0.145	0.217	CbGbCtD
Ofloxacin—ABCC1—Epirubicin—ovarian cancer	0.0805	0.12	CbGbCtD
Ofloxacin—ABCC1—Paclitaxel—ovarian cancer	0.0793	0.118	CbGbCtD
Ofloxacin—TOP2A—Doxorubicin—ovarian cancer	0.0772	0.115	CbGbCtD
Ofloxacin—ABCC2—Paclitaxel—ovarian cancer	0.0587	0.0876	CbGbCtD
Ofloxacin—ABCC1—Docetaxel—ovarian cancer	0.0574	0.0856	CbGbCtD
Ofloxacin—ABCC2—Carboplatin—ovarian cancer	0.0553	0.0825	CbGbCtD
Ofloxacin—ABCC1—Doxorubicin—ovarian cancer	0.0428	0.0638	CbGbCtD
Ofloxacin—ABCC2—Docetaxel—ovarian cancer	0.0425	0.0634	CbGbCtD
Ofloxacin—ABCC2—Doxorubicin—ovarian cancer	0.0317	0.0472	CbGbCtD
Ofloxacin—TOP2A—myometrium—ovarian cancer	0.0022	0.0593	CbGeAlD
Ofloxacin—SLC22A4—myometrium—ovarian cancer	0.00176	0.0474	CbGeAlD
Ofloxacin—TOP2A—uterine cervix—ovarian cancer	0.00171	0.0461	CbGeAlD
Ofloxacin—TOP2A—decidua—ovarian cancer	0.00163	0.0439	CbGeAlD
Ofloxacin—TOP2A—endometrium—ovarian cancer	0.00155	0.0417	CbGeAlD
Ofloxacin—TOP2A—uterus—ovarian cancer	0.00143	0.0384	CbGeAlD
Ofloxacin—ABCC1—myometrium—ovarian cancer	0.00132	0.0357	CbGeAlD
Ofloxacin—SLC22A4—decidua—ovarian cancer	0.0013	0.0352	CbGeAlD
Ofloxacin—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.00124	0.219	CbGdCrCtD
Ofloxacin—SLC22A4—endometrium—ovarian cancer	0.00124	0.0334	CbGeAlD
Ofloxacin—TOP2A—bone marrow—ovarian cancer	0.00121	0.0326	CbGeAlD
Ofloxacin—TOP2A—female gonad—ovarian cancer	0.00117	0.0314	CbGeAlD
Ofloxacin—SLC22A5—myometrium—ovarian cancer	0.00116	0.0314	CbGeAlD
Ofloxacin—TOP2A—vagina—ovarian cancer	0.00116	0.0313	CbGeAlD
Ofloxacin—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.00106	0.187	CbGdCrCtD
Ofloxacin—TOP2A—testis—ovarian cancer	0.00103	0.0279	CbGeAlD
Ofloxacin—ABCC1—uterine cervix—ovarian cancer	0.00103	0.0278	CbGeAlD
Ofloxacin—SLC22A4—female reproductive system—ovarian cancer	0.00103	0.0277	CbGeAlD
Ofloxacin—ABCC1—decidua—ovarian cancer	0.000982	0.0265	CbGeAlD
Ofloxacin—SLC22A4—bone marrow—ovarian cancer	0.000969	0.0261	CbGeAlD
Ofloxacin—ABCC1—endometrium—ovarian cancer	0.000932	0.0251	CbGeAlD
Ofloxacin—SLC22A4—vagina—ovarian cancer	0.000928	0.025	CbGeAlD
Ofloxacin—SLC22A5—uterine cervix—ovarian cancer	0.000906	0.0244	CbGeAlD
Ofloxacin—ABCC2—female reproductive system—ovarian cancer	0.000877	0.0236	CbGeAlD
Ofloxacin—ABCC1—uterus—ovarian cancer	0.000859	0.0231	CbGeAlD
Ofloxacin—SLC22A5—endometrium—ovarian cancer	0.00082	0.0221	CbGeAlD
Ofloxacin—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.000788	0.139	CbGdCrCtD
Ofloxacin—TOP2A—lymph node—ovarian cancer	0.00075	0.0202	CbGeAlD
Ofloxacin—ABCC2—testis—ovarian cancer	0.000707	0.0191	CbGeAlD
Ofloxacin—ABCC1—female gonad—ovarian cancer	0.000703	0.0189	CbGeAlD
Ofloxacin—ABCC1—vagina—ovarian cancer	0.000698	0.0188	CbGeAlD
Ofloxacin—SLC22A5—female reproductive system—ovarian cancer	0.000679	0.0183	CbGeAlD
Ofloxacin—ABCC1—testis—ovarian cancer	0.000623	0.0168	CbGeAlD
Ofloxacin—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	0.000618	0.109	CbGdCrCtD
Ofloxacin—SLC22A5—female gonad—ovarian cancer	0.000618	0.0167	CbGeAlD
Ofloxacin—SLC22A5—vagina—ovarian cancer	0.000614	0.0165	CbGeAlD
Ofloxacin—SLC22A4—lymph node—ovarian cancer	0.0006	0.0162	CbGeAlD
Ofloxacin—SLC22A5—testis—ovarian cancer	0.000548	0.0148	CbGeAlD
Ofloxacin—ABCC2—lymph node—ovarian cancer	0.000513	0.0138	CbGeAlD
Ofloxacin—ABCC1—lymph node—ovarian cancer	0.000452	0.0122	CbGeAlD
Ofloxacin—TOP2A—Vincristine—Vinorelbine—ovarian cancer	0.000425	0.075	CbGdCrCtD
Ofloxacin—SLC22A5—lymph node—ovarian cancer	0.000397	0.0107	CbGeAlD
Ofloxacin—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	0.000342	0.0603	CbGdCrCtD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000251	0.0114	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—ovarian cancer	0.000247	0.0112	CbGpPWpGaD
Ofloxacin—Sparfloxacin—ABCB1—ovarian cancer	0.000243	0.42	CrCbGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TOP1—ovarian cancer	0.000241	0.011	CbGpPWpGaD
Ofloxacin—ABCC2—ABC-family proteins mediated transport—ABCB1—ovarian cancer	0.00024	0.0109	CbGpPWpGaD
Ofloxacin—ABCC1—ABC-family proteins mediated transport—ABCB1—ovarian cancer	0.000237	0.0108	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000221	0.0101	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000211	0.00961	CbGpPWpGaD
Ofloxacin—TOP2A—Idarubicin—Epirubicin—ovarian cancer	0.000207	0.0365	CbGdCrCtD
Ofloxacin—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	0.000207	0.0365	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	0.000207	0.0365	CbGdCrCtD
Ofloxacin—TOP2A—Cell Cycle—RSF1—ovarian cancer	0.000207	0.00943	CbGpPWpGaD
Ofloxacin—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	0.000192	0.0338	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	0.000192	0.0338	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	0.000192	0.0338	CbGdCrCtD
Ofloxacin—CYP1A2—Estrogen metabolism—CYP1B1—ovarian cancer	0.00019	0.00867	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—ovarian cancer	0.000189	0.00861	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—HNF1B—ovarian cancer	0.000183	0.00833	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—SKP2—ovarian cancer	0.000177	0.00807	CbGpPWpGaD
Ofloxacin—Levofloxacin—ABCB1—ovarian cancer	0.000171	0.295	CrCbGaD
Ofloxacin—ABCC1—S1P1 pathway—VEGFA—ovarian cancer	0.00017	0.00776	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.000169	0.0077	CbGpPWpGaD
Ofloxacin—CYP1A2—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000168	0.00766	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—ovarian cancer	0.000166	0.00756	CbGpPWpGaD
Ofloxacin—Ciprofloxacin—ABCB1—ovarian cancer	0.000165	0.285	CrCbGaD
Ofloxacin—ABCC1—S1P1 pathway—MAPK3—ovarian cancer	0.000161	0.00734	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—FASN—ovarian cancer	0.000156	0.0071	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—ESR1—ovarian cancer	0.000155	0.00706	CbGpPWpGaD
Ofloxacin—ABCC1—S1P1 pathway—MAPK1—ovarian cancer	0.000153	0.00698	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—MYC—ovarian cancer	0.000153	0.00697	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—ovarian cancer	0.00015	0.00682	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—ovarian cancer	0.000148	0.00675	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—ovarian cancer	0.000136	0.00618	CbGpPWpGaD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.00013	0.00592	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—PPP2R1A—ovarian cancer	0.000128	0.00583	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—TP53—ovarian cancer	0.000126	0.00572	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.00012	0.00547	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCNE1—ovarian cancer	0.000119	0.00542	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000118	0.00538	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000118	0.00536	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—ovarian cancer	0.000117	0.00532	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000114	0.00518	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000113	0.00516	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.00011	0.005	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RAD51C—ovarian cancer	0.000109	0.00496	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.000106	0.00484	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000103	0.00468	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—SLC5A5—ovarian cancer	0.000102	0.00467	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—SLC2A1—ovarian cancer	9.9e-05	0.00451	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ovarian cancer	9.75e-05	0.00445	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—PPP1CC—ovarian cancer	9.5e-05	0.00433	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	9.41e-05	0.00429	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	9.29e-05	0.00424	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	9e-05	0.0041	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	9e-05	0.0041	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	8.97e-05	0.00409	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	8.97e-05	0.00409	CbGpPWpGaD
Ofloxacin—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	8.97e-05	0.00409	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.95e-05	0.00408	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—AQP3—ovarian cancer	8.88e-05	0.00405	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	8.84e-05	0.00403	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	8.83e-05	0.00403	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	8.75e-05	0.00399	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RBL2—ovarian cancer	8.72e-05	0.00398	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	8.67e-05	0.00395	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	8.53e-05	0.00389	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	8.51e-05	0.00388	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TYMS—ovarian cancer	8.49e-05	0.00387	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	8.39e-05	0.00383	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	8.35e-05	0.00381	CbGpPWpGaD
Ofloxacin—Photosensitivity reaction—Doxorubicin—ovarian cancer	8.2e-05	0.00031	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Epirubicin—ovarian cancer	8.19e-05	0.00031	CcSEcCtD
Ofloxacin—Anaphylactic shock—Docetaxel—ovarian cancer	8.19e-05	0.00031	CcSEcCtD
Ofloxacin—Oedema—Docetaxel—ovarian cancer	8.19e-05	0.00031	CcSEcCtD
Ofloxacin—Epistaxis—Epirubicin—ovarian cancer	8.17e-05	0.000309	CcSEcCtD
Ofloxacin—Infection—Docetaxel—ovarian cancer	8.14e-05	0.000308	CcSEcCtD
Ofloxacin—Weight decreased—Doxorubicin—ovarian cancer	8.13e-05	0.000307	CcSEcCtD
Ofloxacin—Sinusitis—Epirubicin—ovarian cancer	8.13e-05	0.000307	CcSEcCtD
Ofloxacin—Hyperglycaemia—Doxorubicin—ovarian cancer	8.11e-05	0.000306	CcSEcCtD
Ofloxacin—Agranulocytosis—Epirubicin—ovarian cancer	8.08e-05	0.000306	CcSEcCtD
Ofloxacin—Pneumonia—Doxorubicin—ovarian cancer	8.06e-05	0.000305	CcSEcCtD
Ofloxacin—Shock—Docetaxel—ovarian cancer	8.06e-05	0.000305	CcSEcCtD
Ofloxacin—Nervous system disorder—Docetaxel—ovarian cancer	8.03e-05	0.000304	CcSEcCtD
Ofloxacin—Thrombocytopenia—Docetaxel—ovarian cancer	8.02e-05	0.000303	CcSEcCtD
Ofloxacin—Infestation NOS—Doxorubicin—ovarian cancer	8.01e-05	0.000303	CcSEcCtD
Ofloxacin—Infestation—Doxorubicin—ovarian cancer	8.01e-05	0.000303	CcSEcCtD
Ofloxacin—Drowsiness—Doxorubicin—ovarian cancer	8.01e-05	0.000303	CcSEcCtD
Ofloxacin—Tachycardia—Docetaxel—ovarian cancer	7.99e-05	0.000302	CcSEcCtD
Ofloxacin—Feeling abnormal—Paclitaxel—ovarian cancer	7.96e-05	0.000301	CcSEcCtD
Ofloxacin—Skin disorder—Docetaxel—ovarian cancer	7.95e-05	0.000301	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	7.94e-05	0.0003	CcSEcCtD
Ofloxacin—Bradycardia—Epirubicin—ovarian cancer	7.91e-05	0.000299	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Paclitaxel—ovarian cancer	7.9e-05	0.000299	CcSEcCtD
Ofloxacin—Renal failure—Doxorubicin—ovarian cancer	7.88e-05	0.000298	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Doxorubicin—ovarian cancer	7.85e-05	0.000297	CcSEcCtD
Ofloxacin—Haemoglobin—Epirubicin—ovarian cancer	7.81e-05	0.000295	CcSEcCtD
Ofloxacin—Stomatitis—Doxorubicin—ovarian cancer	7.81e-05	0.000295	CcSEcCtD
Ofloxacin—Jaundice—Doxorubicin—ovarian cancer	7.81e-05	0.000295	CcSEcCtD
Ofloxacin—Anorexia—Docetaxel—ovarian cancer	7.81e-05	0.000295	CcSEcCtD
Ofloxacin—Rhinitis—Epirubicin—ovarian cancer	7.79e-05	0.000295	CcSEcCtD
Ofloxacin—Conjunctivitis—Doxorubicin—ovarian cancer	7.79e-05	0.000294	CcSEcCtD
Ofloxacin—Haemorrhage—Epirubicin—ovarian cancer	7.77e-05	0.000294	CcSEcCtD
Ofloxacin—Hepatitis—Epirubicin—ovarian cancer	7.77e-05	0.000294	CcSEcCtD
Ofloxacin—Hypoaesthesia—Epirubicin—ovarian cancer	7.74e-05	0.000292	CcSEcCtD
Ofloxacin—Pharyngitis—Epirubicin—ovarian cancer	7.72e-05	0.000292	CcSEcCtD
Ofloxacin—Urinary tract disorder—Epirubicin—ovarian cancer	7.68e-05	0.00029	CcSEcCtD
Ofloxacin—Urticaria—Paclitaxel—ovarian cancer	7.68e-05	0.00029	CcSEcCtD
Ofloxacin—Oedema peripheral—Epirubicin—ovarian cancer	7.66e-05	0.00029	CcSEcCtD
Ofloxacin—Hypotension—Docetaxel—ovarian cancer	7.65e-05	0.000289	CcSEcCtD
Ofloxacin—Haematuria—Doxorubicin—ovarian cancer	7.64e-05	0.000289	CcSEcCtD
Ofloxacin—Connective tissue disorder—Epirubicin—ovarian cancer	7.64e-05	0.000289	CcSEcCtD
Ofloxacin—Abdominal pain—Paclitaxel—ovarian cancer	7.64e-05	0.000289	CcSEcCtD
Ofloxacin—Body temperature increased—Paclitaxel—ovarian cancer	7.64e-05	0.000289	CcSEcCtD
Ofloxacin—Urethral disorder—Epirubicin—ovarian cancer	7.62e-05	0.000288	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Doxorubicin—ovarian cancer	7.58e-05	0.000286	CcSEcCtD
Ofloxacin—Epistaxis—Doxorubicin—ovarian cancer	7.56e-05	0.000286	CcSEcCtD
Ofloxacin—Sinusitis—Doxorubicin—ovarian cancer	7.52e-05	0.000284	CcSEcCtD
Ofloxacin—Visual impairment—Epirubicin—ovarian cancer	7.49e-05	0.000283	CcSEcCtD
Ofloxacin—Agranulocytosis—Doxorubicin—ovarian cancer	7.48e-05	0.000283	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	7.46e-05	0.000282	CcSEcCtD
Ofloxacin—Insomnia—Docetaxel—ovarian cancer	7.41e-05	0.00028	CcSEcCtD
Ofloxacin—Paraesthesia—Docetaxel—ovarian cancer	7.35e-05	0.000278	CcSEcCtD
Ofloxacin—Erythema multiforme—Epirubicin—ovarian cancer	7.35e-05	0.000278	CcSEcCtD
Ofloxacin—Bradycardia—Doxorubicin—ovarian cancer	7.32e-05	0.000277	CcSEcCtD
Ofloxacin—Dyspnoea—Docetaxel—ovarian cancer	7.3e-05	0.000276	CcSEcCtD
Ofloxacin—Somnolence—Docetaxel—ovarian cancer	7.28e-05	0.000275	CcSEcCtD
Ofloxacin—Eye disorder—Epirubicin—ovarian cancer	7.27e-05	0.000275	CcSEcCtD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	7.25e-05	0.00331	CbGpPWpGaD
Ofloxacin—Tinnitus—Epirubicin—ovarian cancer	7.25e-05	0.000274	CcSEcCtD
Ofloxacin—Haemoglobin—Doxorubicin—ovarian cancer	7.23e-05	0.000273	CcSEcCtD
Ofloxacin—Flushing—Epirubicin—ovarian cancer	7.22e-05	0.000273	CcSEcCtD
Ofloxacin—Cardiac disorder—Epirubicin—ovarian cancer	7.22e-05	0.000273	CcSEcCtD
Ofloxacin—Rhinitis—Doxorubicin—ovarian cancer	7.21e-05	0.000273	CcSEcCtD
Ofloxacin—Dyspepsia—Docetaxel—ovarian cancer	7.21e-05	0.000272	CcSEcCtD
Ofloxacin—Haemorrhage—Doxorubicin—ovarian cancer	7.19e-05	0.000272	CcSEcCtD
Ofloxacin—Hepatitis—Doxorubicin—ovarian cancer	7.19e-05	0.000272	CcSEcCtD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	7.16e-05	0.00326	CbGpPWpGaD
Ofloxacin—Hypoaesthesia—Doxorubicin—ovarian cancer	7.16e-05	0.000271	CcSEcCtD
Ofloxacin—Pharyngitis—Doxorubicin—ovarian cancer	7.14e-05	0.00027	CcSEcCtD
Ofloxacin—Decreased appetite—Docetaxel—ovarian cancer	7.12e-05	0.000269	CcSEcCtD
Ofloxacin—Hypersensitivity—Paclitaxel—ovarian cancer	7.12e-05	0.000269	CcSEcCtD
Ofloxacin—Urinary tract disorder—Doxorubicin—ovarian cancer	7.1e-05	0.000269	CcSEcCtD
Ofloxacin—Oedema peripheral—Doxorubicin—ovarian cancer	7.09e-05	0.000268	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Docetaxel—ovarian cancer	7.07e-05	0.000267	CcSEcCtD
Ofloxacin—Connective tissue disorder—Doxorubicin—ovarian cancer	7.07e-05	0.000267	CcSEcCtD
Ofloxacin—Fatigue—Docetaxel—ovarian cancer	7.06e-05	0.000267	CcSEcCtD
Ofloxacin—Angiopathy—Epirubicin—ovarian cancer	7.05e-05	0.000267	CcSEcCtD
Ofloxacin—Urethral disorder—Doxorubicin—ovarian cancer	7.05e-05	0.000267	CcSEcCtD
Ofloxacin—Immune system disorder—Epirubicin—ovarian cancer	7.02e-05	0.000265	CcSEcCtD
Ofloxacin—Mediastinal disorder—Epirubicin—ovarian cancer	7.01e-05	0.000265	CcSEcCtD
Ofloxacin—Constipation—Docetaxel—ovarian cancer	7e-05	0.000265	CcSEcCtD
Ofloxacin—Pain—Docetaxel—ovarian cancer	7e-05	0.000265	CcSEcCtD
Ofloxacin—Chills—Epirubicin—ovarian cancer	6.98e-05	0.000264	CcSEcCtD
Ofloxacin—Arrhythmia—Epirubicin—ovarian cancer	6.95e-05	0.000263	CcSEcCtD
Ofloxacin—Visual impairment—Doxorubicin—ovarian cancer	6.93e-05	0.000262	CcSEcCtD
Ofloxacin—Asthenia—Paclitaxel—ovarian cancer	6.93e-05	0.000262	CcSEcCtD
Ofloxacin—Alopecia—Epirubicin—ovarian cancer	6.87e-05	0.00026	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	6.86e-05	0.00313	CbGpPWpGaD
Ofloxacin—Pruritus—Paclitaxel—ovarian cancer	6.84e-05	0.000258	CcSEcCtD
Ofloxacin—Mental disorder—Epirubicin—ovarian cancer	6.81e-05	0.000257	CcSEcCtD
Ofloxacin—Erythema multiforme—Doxorubicin—ovarian cancer	6.8e-05	0.000257	CcSEcCtD
Ofloxacin—Malnutrition—Epirubicin—ovarian cancer	6.77e-05	0.000256	CcSEcCtD
Ofloxacin—Erythema—Epirubicin—ovarian cancer	6.77e-05	0.000256	CcSEcCtD
Ofloxacin—Feeling abnormal—Docetaxel—ovarian cancer	6.75e-05	0.000255	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	6.73e-05	0.00307	CbGpPWpGaD
Ofloxacin—Eye disorder—Doxorubicin—ovarian cancer	6.72e-05	0.000254	CcSEcCtD
Ofloxacin—Tinnitus—Doxorubicin—ovarian cancer	6.71e-05	0.000254	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—AQP3—ovarian cancer	6.7e-05	0.00306	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	6.7e-05	0.00305	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Docetaxel—ovarian cancer	6.7e-05	0.000253	CcSEcCtD
Ofloxacin—Flushing—Doxorubicin—ovarian cancer	6.68e-05	0.000252	CcSEcCtD
Ofloxacin—Cardiac disorder—Doxorubicin—ovarian cancer	6.68e-05	0.000252	CcSEcCtD
Ofloxacin—Flatulence—Epirubicin—ovarian cancer	6.67e-05	0.000252	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	6.67e-05	0.00304	CbGpPWpGaD
Ofloxacin—Tension—Epirubicin—ovarian cancer	6.64e-05	0.000251	CcSEcCtD
Ofloxacin—Dysgeusia—Epirubicin—ovarian cancer	6.63e-05	0.000251	CcSEcCtD
Ofloxacin—Diarrhoea—Paclitaxel—ovarian cancer	6.61e-05	0.00025	CcSEcCtD
Ofloxacin—Nervousness—Epirubicin—ovarian cancer	6.57e-05	0.000248	CcSEcCtD
Ofloxacin—ABCC1—Disease—HSD17B6—ovarian cancer	6.55e-05	0.00299	CbGpPWpGaD
Ofloxacin—Back pain—Epirubicin—ovarian cancer	6.55e-05	0.000247	CcSEcCtD
Ofloxacin—Angiopathy—Doxorubicin—ovarian cancer	6.53e-05	0.000247	CcSEcCtD
Ofloxacin—Muscle spasms—Epirubicin—ovarian cancer	6.51e-05	0.000246	CcSEcCtD
Ofloxacin—Immune system disorder—Doxorubicin—ovarian cancer	6.5e-05	0.000246	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—AQP3—ovarian cancer	6.49e-05	0.00296	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—ovarian cancer	6.49e-05	0.00296	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	6.49e-05	0.00296	CbGpPWpGaD
Ofloxacin—Mediastinal disorder—Doxorubicin—ovarian cancer	6.48e-05	0.000245	CcSEcCtD
Ofloxacin—Body temperature increased—Docetaxel—ovarian cancer	6.47e-05	0.000245	CcSEcCtD
Ofloxacin—Abdominal pain—Docetaxel—ovarian cancer	6.47e-05	0.000245	CcSEcCtD
Ofloxacin—Chills—Doxorubicin—ovarian cancer	6.45e-05	0.000244	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	6.44e-05	0.00294	CbGpPWpGaD
Ofloxacin—Arrhythmia—Doxorubicin—ovarian cancer	6.43e-05	0.000243	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	6.42e-05	0.00293	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—AQP3—ovarian cancer	6.42e-05	0.00292	CbGpPWpGaD
Ofloxacin—Dizziness—Paclitaxel—ovarian cancer	6.39e-05	0.000242	CcSEcCtD
Ofloxacin—Vision blurred—Epirubicin—ovarian cancer	6.38e-05	0.000241	CcSEcCtD
Ofloxacin—Alopecia—Doxorubicin—ovarian cancer	6.36e-05	0.00024	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	6.34e-05	0.00289	CbGpPWpGaD
Ofloxacin—Mental disorder—Doxorubicin—ovarian cancer	6.3e-05	0.000238	CcSEcCtD
Ofloxacin—Ill-defined disorder—Epirubicin—ovarian cancer	6.28e-05	0.000237	CcSEcCtD
Ofloxacin—Erythema—Doxorubicin—ovarian cancer	6.26e-05	0.000237	CcSEcCtD
Ofloxacin—Malnutrition—Doxorubicin—ovarian cancer	6.26e-05	0.000237	CcSEcCtD
Ofloxacin—Anaemia—Epirubicin—ovarian cancer	6.26e-05	0.000236	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	6.22e-05	0.00284	CbGpPWpGaD
Ofloxacin—Agitation—Epirubicin—ovarian cancer	6.22e-05	0.000235	CcSEcCtD
Ofloxacin—Flatulence—Doxorubicin—ovarian cancer	6.17e-05	0.000233	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	6.16e-05	0.00281	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	6.15e-05	0.0028	CbGpPWpGaD
Ofloxacin—Tension—Doxorubicin—ovarian cancer	6.15e-05	0.000232	CcSEcCtD
Ofloxacin—Vomiting—Paclitaxel—ovarian cancer	6.14e-05	0.000232	CcSEcCtD
Ofloxacin—Dysgeusia—Doxorubicin—ovarian cancer	6.13e-05	0.000232	CcSEcCtD
Ofloxacin—Malaise—Epirubicin—ovarian cancer	6.1e-05	0.000231	CcSEcCtD
Ofloxacin—Rash—Paclitaxel—ovarian cancer	6.09e-05	0.00023	CcSEcCtD
Ofloxacin—Dermatitis—Paclitaxel—ovarian cancer	6.09e-05	0.00023	CcSEcCtD
Ofloxacin—Nervousness—Doxorubicin—ovarian cancer	6.08e-05	0.00023	CcSEcCtD
Ofloxacin—Vertigo—Epirubicin—ovarian cancer	6.08e-05	0.00023	CcSEcCtD
Ofloxacin—Syncope—Epirubicin—ovarian cancer	6.07e-05	0.000229	CcSEcCtD
Ofloxacin—Leukopenia—Epirubicin—ovarian cancer	6.06e-05	0.000229	CcSEcCtD
Ofloxacin—Back pain—Doxorubicin—ovarian cancer	6.06e-05	0.000229	CcSEcCtD
Ofloxacin—Headache—Paclitaxel—ovarian cancer	6.05e-05	0.000229	CcSEcCtD
Ofloxacin—Hypersensitivity—Docetaxel—ovarian cancer	6.03e-05	0.000228	CcSEcCtD
Ofloxacin—Muscle spasms—Doxorubicin—ovarian cancer	6.02e-05	0.000228	CcSEcCtD
Ofloxacin—Palpitations—Epirubicin—ovarian cancer	5.98e-05	0.000226	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.97e-05	0.00272	CbGpPWpGaD
Ofloxacin—Loss of consciousness—Epirubicin—ovarian cancer	5.95e-05	0.000225	CcSEcCtD
Ofloxacin—Cough—Epirubicin—ovarian cancer	5.91e-05	0.000223	CcSEcCtD
Ofloxacin—Vision blurred—Doxorubicin—ovarian cancer	5.9e-05	0.000223	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	5.88e-05	0.00268	CbGpPWpGaD
Ofloxacin—Asthenia—Docetaxel—ovarian cancer	5.88e-05	0.000222	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ovarian cancer	5.87e-05	0.00268	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MLH1—ovarian cancer	5.87e-05	0.00268	CbGpPWpGaD
Ofloxacin—Hypertension—Epirubicin—ovarian cancer	5.84e-05	0.000221	CcSEcCtD
Ofloxacin—Ill-defined disorder—Doxorubicin—ovarian cancer	5.81e-05	0.00022	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—SKP2—ovarian cancer	5.8e-05	0.00265	CbGpPWpGaD
Ofloxacin—Pruritus—Docetaxel—ovarian cancer	5.79e-05	0.000219	CcSEcCtD
Ofloxacin—Anaemia—Doxorubicin—ovarian cancer	5.79e-05	0.000219	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.77e-05	0.00263	CbGpPWpGaD
Ofloxacin—Chest pain—Epirubicin—ovarian cancer	5.76e-05	0.000218	CcSEcCtD
Ofloxacin—Myalgia—Epirubicin—ovarian cancer	5.76e-05	0.000218	CcSEcCtD
Ofloxacin—Arthralgia—Epirubicin—ovarian cancer	5.76e-05	0.000218	CcSEcCtD
Ofloxacin—Agitation—Doxorubicin—ovarian cancer	5.75e-05	0.000218	CcSEcCtD
Ofloxacin—Anxiety—Epirubicin—ovarian cancer	5.74e-05	0.000217	CcSEcCtD
Ofloxacin—Nausea—Paclitaxel—ovarian cancer	5.74e-05	0.000217	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	5.72e-05	0.000216	CcSEcCtD
Ofloxacin—Discomfort—Epirubicin—ovarian cancer	5.69e-05	0.000215	CcSEcCtD
Ofloxacin—Malaise—Doxorubicin—ovarian cancer	5.65e-05	0.000213	CcSEcCtD
Ofloxacin—Dry mouth—Epirubicin—ovarian cancer	5.64e-05	0.000213	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	5.63e-05	0.00257	CbGpPWpGaD
Ofloxacin—Vertigo—Doxorubicin—ovarian cancer	5.63e-05	0.000213	CcSEcCtD
Ofloxacin—Syncope—Doxorubicin—ovarian cancer	5.62e-05	0.000212	CcSEcCtD
Ofloxacin—Leukopenia—Doxorubicin—ovarian cancer	5.61e-05	0.000212	CcSEcCtD
Ofloxacin—Diarrhoea—Docetaxel—ovarian cancer	5.6e-05	0.000212	CcSEcCtD
Ofloxacin—Confusional state—Epirubicin—ovarian cancer	5.57e-05	0.000211	CcSEcCtD
Ofloxacin—Palpitations—Doxorubicin—ovarian cancer	5.53e-05	0.000209	CcSEcCtD
Ofloxacin—Oedema—Epirubicin—ovarian cancer	5.52e-05	0.000209	CcSEcCtD
Ofloxacin—Anaphylactic shock—Epirubicin—ovarian cancer	5.52e-05	0.000209	CcSEcCtD
Ofloxacin—Loss of consciousness—Doxorubicin—ovarian cancer	5.5e-05	0.000208	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	5.5e-05	0.00251	CbGpPWpGaD
Ofloxacin—Infection—Epirubicin—ovarian cancer	5.49e-05	0.000207	CcSEcCtD
Ofloxacin—Cough—Doxorubicin—ovarian cancer	5.46e-05	0.000207	CcSEcCtD
Ofloxacin—Shock—Epirubicin—ovarian cancer	5.43e-05	0.000205	CcSEcCtD
Ofloxacin—Nervous system disorder—Epirubicin—ovarian cancer	5.42e-05	0.000205	CcSEcCtD
Ofloxacin—Dizziness—Docetaxel—ovarian cancer	5.42e-05	0.000205	CcSEcCtD
Ofloxacin—Thrombocytopenia—Epirubicin—ovarian cancer	5.41e-05	0.000204	CcSEcCtD
Ofloxacin—Hypertension—Doxorubicin—ovarian cancer	5.41e-05	0.000204	CcSEcCtD
Ofloxacin—Tachycardia—Epirubicin—ovarian cancer	5.39e-05	0.000204	CcSEcCtD
Ofloxacin—Skin disorder—Epirubicin—ovarian cancer	5.37e-05	0.000203	CcSEcCtD
Ofloxacin—Hyperhidrosis—Epirubicin—ovarian cancer	5.34e-05	0.000202	CcSEcCtD
Ofloxacin—Chest pain—Doxorubicin—ovarian cancer	5.33e-05	0.000202	CcSEcCtD
Ofloxacin—Myalgia—Doxorubicin—ovarian cancer	5.33e-05	0.000202	CcSEcCtD
Ofloxacin—Arthralgia—Doxorubicin—ovarian cancer	5.33e-05	0.000202	CcSEcCtD
Ofloxacin—Anxiety—Doxorubicin—ovarian cancer	5.31e-05	0.000201	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	5.29e-05	0.0002	CcSEcCtD
Ofloxacin—Discomfort—Doxorubicin—ovarian cancer	5.27e-05	0.000199	CcSEcCtD
Ofloxacin—Anorexia—Epirubicin—ovarian cancer	5.27e-05	0.000199	CcSEcCtD
Ofloxacin—ABCC1—Disease—CHMP4C—ovarian cancer	5.23e-05	0.00239	CbGpPWpGaD
Ofloxacin—Dry mouth—Doxorubicin—ovarian cancer	5.21e-05	0.000197	CcSEcCtD
Ofloxacin—Vomiting—Docetaxel—ovarian cancer	5.21e-05	0.000197	CcSEcCtD
Ofloxacin—Rash—Docetaxel—ovarian cancer	5.16e-05	0.000195	CcSEcCtD
Ofloxacin—Hypotension—Epirubicin—ovarian cancer	5.16e-05	0.000195	CcSEcCtD
Ofloxacin—Dermatitis—Docetaxel—ovarian cancer	5.16e-05	0.000195	CcSEcCtD
Ofloxacin—Confusional state—Doxorubicin—ovarian cancer	5.15e-05	0.000195	CcSEcCtD
Ofloxacin—Headache—Docetaxel—ovarian cancer	5.13e-05	0.000194	CcSEcCtD
Ofloxacin—Oedema—Doxorubicin—ovarian cancer	5.11e-05	0.000193	CcSEcCtD
Ofloxacin—Anaphylactic shock—Doxorubicin—ovarian cancer	5.11e-05	0.000193	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	5.08e-05	0.00232	CbGpPWpGaD
Ofloxacin—Infection—Doxorubicin—ovarian cancer	5.08e-05	0.000192	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	5.04e-05	0.0023	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	5.03e-05	0.00019	CcSEcCtD
Ofloxacin—Shock—Doxorubicin—ovarian cancer	5.03e-05	0.00019	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—NME2—ovarian cancer	5.02e-05	0.00229	CbGpPWpGaD
Ofloxacin—Nervous system disorder—Doxorubicin—ovarian cancer	5.01e-05	0.000189	CcSEcCtD
Ofloxacin—Thrombocytopenia—Doxorubicin—ovarian cancer	5e-05	0.000189	CcSEcCtD
Ofloxacin—Insomnia—Epirubicin—ovarian cancer	5e-05	0.000189	CcSEcCtD
Ofloxacin—Tachycardia—Doxorubicin—ovarian cancer	4.99e-05	0.000189	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ovarian cancer	4.97e-05	0.00227	CbGpPWpGaD
Ofloxacin—Skin disorder—Doxorubicin—ovarian cancer	4.96e-05	0.000188	CcSEcCtD
Ofloxacin—Paraesthesia—Epirubicin—ovarian cancer	4.96e-05	0.000187	CcSEcCtD
Ofloxacin—Hyperhidrosis—Doxorubicin—ovarian cancer	4.94e-05	0.000187	CcSEcCtD
Ofloxacin—Dyspnoea—Epirubicin—ovarian cancer	4.92e-05	0.000186	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.92e-05	0.00224	CbGpPWpGaD
Ofloxacin—Somnolence—Epirubicin—ovarian cancer	4.91e-05	0.000186	CcSEcCtD
Ofloxacin—Anorexia—Doxorubicin—ovarian cancer	4.87e-05	0.000184	CcSEcCtD
Ofloxacin—Nausea—Docetaxel—ovarian cancer	4.86e-05	0.000184	CcSEcCtD
Ofloxacin—Dyspepsia—Epirubicin—ovarian cancer	4.86e-05	0.000184	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.86e-05	0.00222	CbGpPWpGaD
Ofloxacin—Decreased appetite—Epirubicin—ovarian cancer	4.8e-05	0.000181	CcSEcCtD
Ofloxacin—Hypotension—Doxorubicin—ovarian cancer	4.78e-05	0.000181	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.77e-05	0.00018	CcSEcCtD
Ofloxacin—Fatigue—Epirubicin—ovarian cancer	4.76e-05	0.00018	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—CHEK2—ovarian cancer	4.75e-05	0.00216	CbGpPWpGaD
Ofloxacin—Pain—Epirubicin—ovarian cancer	4.72e-05	0.000179	CcSEcCtD
Ofloxacin—Constipation—Epirubicin—ovarian cancer	4.72e-05	0.000179	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ovarian cancer	4.71e-05	0.00215	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	4.69e-05	0.00214	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	4.67e-05	0.00213	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	4.66e-05	0.000176	CcSEcCtD
Ofloxacin—Insomnia—Doxorubicin—ovarian cancer	4.62e-05	0.000175	CcSEcCtD
Ofloxacin—Paraesthesia—Doxorubicin—ovarian cancer	4.59e-05	0.000173	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	4.57e-05	0.00208	CbGpPWpGaD
Ofloxacin—Dyspnoea—Doxorubicin—ovarian cancer	4.56e-05	0.000172	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.55e-05	0.00208	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Epirubicin—ovarian cancer	4.55e-05	0.000172	CcSEcCtD
Ofloxacin—Somnolence—Doxorubicin—ovarian cancer	4.54e-05	0.000172	CcSEcCtD
Ofloxacin—ABCC1—Disease—BCL9—ovarian cancer	4.54e-05	0.00207	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Epirubicin—ovarian cancer	4.52e-05	0.000171	CcSEcCtD
Ofloxacin—Dyspepsia—Doxorubicin—ovarian cancer	4.5e-05	0.00017	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.49e-05	0.00205	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	4.45e-05	0.00203	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCND2—ovarian cancer	4.45e-05	0.00203	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—BRCA1—ovarian cancer	4.45e-05	0.00203	CbGpPWpGaD
Ofloxacin—Decreased appetite—Doxorubicin—ovarian cancer	4.44e-05	0.000168	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	4.41e-05	0.000167	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	4.41e-05	0.00201	CbGpPWpGaD
Ofloxacin—Fatigue—Doxorubicin—ovarian cancer	4.41e-05	0.000167	CcSEcCtD
Ofloxacin—Urticaria—Epirubicin—ovarian cancer	4.39e-05	0.000166	CcSEcCtD
Ofloxacin—Constipation—Doxorubicin—ovarian cancer	4.37e-05	0.000165	CcSEcCtD
Ofloxacin—Pain—Doxorubicin—ovarian cancer	4.37e-05	0.000165	CcSEcCtD
Ofloxacin—Body temperature increased—Epirubicin—ovarian cancer	4.37e-05	0.000165	CcSEcCtD
Ofloxacin—Abdominal pain—Epirubicin—ovarian cancer	4.37e-05	0.000165	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	4.36e-05	0.00199	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.34e-05	0.00198	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	4.3e-05	0.00196	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—ovarian cancer	4.28e-05	0.00195	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.25e-05	0.00194	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Doxorubicin—ovarian cancer	4.21e-05	0.000159	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—PPP2R1A—ovarian cancer	4.2e-05	0.00191	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Doxorubicin—ovarian cancer	4.18e-05	0.000158	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—PTEN—ovarian cancer	4.12e-05	0.00188	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Epirubicin—ovarian cancer	4.07e-05	0.000154	CcSEcCtD
Ofloxacin—Urticaria—Doxorubicin—ovarian cancer	4.06e-05	0.000153	CcSEcCtD
Ofloxacin—Body temperature increased—Doxorubicin—ovarian cancer	4.04e-05	0.000153	CcSEcCtD
Ofloxacin—Abdominal pain—Doxorubicin—ovarian cancer	4.04e-05	0.000153	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—BRCA2—ovarian cancer	4.02e-05	0.00183	CbGpPWpGaD
Ofloxacin—Asthenia—Epirubicin—ovarian cancer	3.96e-05	0.00015	CcSEcCtD
Ofloxacin—Pruritus—Epirubicin—ovarian cancer	3.91e-05	0.000148	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—CCNE1—ovarian cancer	3.9e-05	0.00178	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	3.88e-05	0.00177	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	3.85e-05	0.00175	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	3.83e-05	0.00175	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	3.83e-05	0.00175	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TYMS—ovarian cancer	3.83e-05	0.00174	CbGpPWpGaD
Ofloxacin—Diarrhoea—Epirubicin—ovarian cancer	3.78e-05	0.000143	CcSEcCtD
Ofloxacin—Hypersensitivity—Doxorubicin—ovarian cancer	3.77e-05	0.000142	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	3.75e-05	0.00171	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	3.67e-05	0.00167	CbGpPWpGaD
Ofloxacin—Asthenia—Doxorubicin—ovarian cancer	3.67e-05	0.000139	CcSEcCtD
Ofloxacin—Dizziness—Epirubicin—ovarian cancer	3.65e-05	0.000138	CcSEcCtD
Ofloxacin—Pruritus—Doxorubicin—ovarian cancer	3.62e-05	0.000137	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	3.57e-05	0.00163	CbGpPWpGaD
Ofloxacin—Vomiting—Epirubicin—ovarian cancer	3.51e-05	0.000133	CcSEcCtD
Ofloxacin—Diarrhoea—Doxorubicin—ovarian cancer	3.5e-05	0.000132	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	3.49e-05	0.00159	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	3.49e-05	0.00159	CbGpPWpGaD
Ofloxacin—Rash—Epirubicin—ovarian cancer	3.48e-05	0.000132	CcSEcCtD
Ofloxacin—Dermatitis—Epirubicin—ovarian cancer	3.48e-05	0.000132	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.47e-05	0.00158	CbGpPWpGaD
Ofloxacin—Headache—Epirubicin—ovarian cancer	3.46e-05	0.000131	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—BIRC5—ovarian cancer	3.44e-05	0.00157	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.42e-05	0.00156	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.39e-05	0.00154	CbGpPWpGaD
Ofloxacin—Dizziness—Doxorubicin—ovarian cancer	3.38e-05	0.000128	CcSEcCtD
Ofloxacin—ABCC1—Disease—PPP1CC—ovarian cancer	3.37e-05	0.00154	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TERT—ovarian cancer	3.33e-05	0.00152	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	3.3e-05	0.0015	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.28e-05	0.0015	CbGpPWpGaD
Ofloxacin—Nausea—Epirubicin—ovarian cancer	3.28e-05	0.000124	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.27e-05	0.00149	CbGpPWpGaD
Ofloxacin—Vomiting—Doxorubicin—ovarian cancer	3.25e-05	0.000123	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.24e-05	0.00148	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYTB—ovarian cancer	3.23e-05	0.00147	CbGpPWpGaD
Ofloxacin—Rash—Doxorubicin—ovarian cancer	3.22e-05	0.000122	CcSEcCtD
Ofloxacin—Dermatitis—Doxorubicin—ovarian cancer	3.22e-05	0.000122	CcSEcCtD
Ofloxacin—Headache—Doxorubicin—ovarian cancer	3.2e-05	0.000121	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	3.19e-05	0.00145	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.17e-05	0.00145	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.16e-05	0.00144	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	3.15e-05	0.00143	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.13e-05	0.00143	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	3.12e-05	0.00142	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	3.08e-05	0.0014	CbGpPWpGaD
Ofloxacin—Nausea—Doxorubicin—ovarian cancer	3.04e-05	0.000115	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	3.03e-05	0.00138	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.93e-05	0.00134	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	2.93e-05	0.00134	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	2.87e-05	0.00131	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	2.87e-05	0.00131	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	2.87e-05	0.00131	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPP1CC—ovarian cancer	2.82e-05	0.00129	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—BRIP1—ovarian cancer	2.82e-05	0.00129	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	2.81e-05	0.00128	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	2.71e-05	0.00123	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.58e-05	0.00118	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	2.58e-05	0.00117	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HDAC6—ovarian cancer	2.56e-05	0.00117	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.5e-05	0.00114	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.48e-05	0.00113	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.47e-05	0.00113	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.41e-05	0.0011	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	2.3e-05	0.00105	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	2.26e-05	0.00103	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—XIAP—ovarian cancer	2.22e-05	0.00101	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SMARCA4—ovarian cancer	2.16e-05	0.000985	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	2.15e-05	0.000982	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EREG—ovarian cancer	2.11e-05	0.000961	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.06e-05	0.000939	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	2.02e-05	0.000921	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCND1—ovarian cancer	1.93e-05	0.000878	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NME2—ovarian cancer	1.9e-05	0.000868	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—YAP1—ovarian cancer	1.89e-05	0.000864	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.88e-05	0.000855	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FASN—ovarian cancer	1.84e-05	0.000841	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PARP1—ovarian cancer	1.84e-05	0.000837	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	1.78e-05	0.00081	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC2A1—ovarian cancer	1.75e-05	0.000799	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	1.73e-05	0.000788	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.69e-05	0.000771	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.65e-05	0.000752	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.62e-05	0.000737	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MAPK3—ovarian cancer	1.59e-05	0.000724	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MYC—ovarian cancer	1.55e-05	0.000705	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—FASN—ovarian cancer	1.54e-05	0.000704	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC5A5—ovarian cancer	1.52e-05	0.000693	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MAPK1—ovarian cancer	1.51e-05	0.000689	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PPP2R1A—ovarian cancer	1.49e-05	0.000679	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC2A1—ovarian cancer	1.47e-05	0.000669	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.44e-05	0.000655	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP1B1—ovarian cancer	1.41e-05	0.000641	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.32e-05	0.000601	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—ovarian cancer	1.27e-05	0.000579	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPP2R1A—ovarian cancer	1.25e-05	0.000569	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.24e-05	0.000566	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYTB—ovarian cancer	1.23e-05	0.00056	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.2e-05	0.000547	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TERT—ovarian cancer	1.18e-05	0.00054	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCB1—ovarian cancer	1.16e-05	0.000528	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TYMS—ovarian cancer	1.14e-05	0.000519	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CAV1—ovarian cancer	1.09e-05	0.000499	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.07e-05	0.000489	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.07e-05	0.000489	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6ST—ovarian cancer	1.04e-05	0.000473	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APC—ovarian cancer	9.97e-06	0.000455	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CAV1—ovarian cancer	9.17e-06	0.000418	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CD—ovarian cancer	8.77e-06	0.0004	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.76e-06	0.000399	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CG—ovarian cancer	8.35e-06	0.000381	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.82e-06	0.000356	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ERBB2—ovarian cancer	7.74e-06	0.000353	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTOR—ovarian cancer	7.64e-06	0.000348	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CB—ovarian cancer	7.64e-06	0.000348	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CD—ovarian cancer	7.34e-06	0.000335	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—YAP1—ovarian cancer	7.2e-06	0.000328	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN1B—ovarian cancer	7.17e-06	0.000327	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.12e-06	0.000325	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CTNNB1—ovarian cancer	6.77e-06	0.000309	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTEN—ovarian cancer	6.6e-06	0.000301	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CB—ovarian cancer	6.4e-06	0.000292	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.26e-06	0.000285	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—ovarian cancer	5.9e-06	0.000269	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NRAS—ovarian cancer	5.89e-06	0.000269	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—FASN—ovarian cancer	5.87e-06	0.000267	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC5A5—ovarian cancer	5.77e-06	0.000263	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAPK3—ovarian cancer	5.64e-06	0.000257	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC2A1—ovarian cancer	5.57e-06	0.000254	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTEN—ovarian cancer	5.53e-06	0.000252	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MYC—ovarian cancer	5.49e-06	0.00025	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.46e-06	0.000249	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAPK1—ovarian cancer	5.37e-06	0.000245	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGFR—ovarian cancer	5.37e-06	0.000245	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP1B1—ovarian cancer	5.34e-06	0.000244	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KRAS—ovarian cancer	5.07e-06	0.000231	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.74e-06	0.000216	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.72e-06	0.000215	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CA—ovarian cancer	4.66e-06	0.000212	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCB1—ovarian cancer	4.4e-06	0.000201	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TYMS—ovarian cancer	4.32e-06	0.000197	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HRAS—ovarian cancer	4.31e-06	0.000196	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—ovarian cancer	4.12e-06	0.000188	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CA—ovarian cancer	3.9e-06	0.000178	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—ovarian cancer	3.81e-06	0.000173	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CAV1—ovarian cancer	3.48e-06	0.000159	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.33e-06	0.000152	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—ovarian cancer	3.19e-06	0.000145	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CG—ovarian cancer	3.17e-06	0.000145	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.79e-06	0.000127	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.43e-06	0.000111	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTEN—ovarian cancer	2.1e-06	9.57e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.48e-06	6.75e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—ovarian cancer	1.21e-06	5.52e-05	CbGpPWpGaD
